Thermo Fisher Scientific Inc. (TMO) closed at $654.94 on October 3, 2026, a gain of 0.38% from the prior session. The life sciences and laboratory equipment company carried a market capitalization of $241.26 billion at that price.
Despite the daily uptick, TMO shares declined 2.91% over the past seven days, reflecting some near-term selling pressure. The weekly pullback has partially offset gains made earlier in the month.
Over the broader 30-day window, TMO remained solidly in positive territory, up 7.62%. That longer-term trend suggests the stock has recovered meaningfully from lower levels seen roughly a month prior.
The combination of a positive daily move and a strong 30-day advance, set against a softer seven-day performance, points to a stock navigating choppy short-term conditions while maintaining a more constructive medium-term trajectory based on the available price data.
